Lonza Biologics

lonza.com · Manchester, United States of America

Lonza Biologics is a division of Lonza Group that provides contract development and manufacturing services for biologic drugs, including monoclonal antibodies, recombinant proteins, cell and gene therapies, and other complex biologics for pharmaceutical and biotechnology companies. It offers process development, clinical and commercial-scale manufacturing, and related regulatory and analytical services on a fee-for-service and long-term supply agreement basis. The business generates revenue through outsourced biopharmaceutical manufacturing and development contracts with global life sciences customers.

Revenue
$3.5B
Employees
8,500
Founded
1996
Headquarters
Manchester, United States of America

What 9 Arbolus experts think of Lonza Biologics

The NPS score distribution is strong, with two scores of 10, three scores of 9, and multiple 8s, averaging 8.75. Six out of seven experts providing renewal intent indicated they plan to renew, while one large account is unsure. Stickiness is high, with 87.5% reporting more than one year of use or greater adoption. Key themes: high satisfaction, strong engagement from large enterprise buyers, and some renewal risk concentrated in high-value accounts.Overall Customer Sentiment: Positive

Who reviewed Lonza Biologics

Total customers 9 8 current · 1 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 56% (5)
  • Director 44% (4)
Generalist Partner C-Suite NPS 9 Undecided
Generalist Manager Director NPS 8
Revenue Leader C-Suite NPS 8 Will renew

Employer names and spend open once the report publishes.

Tell us when the Lonza Biologics report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

44 Net Promoter Score, from 9 scored reviews
  • Promoters 4
  • Passives 5
  • Detractors 0

Cumulative NPS by month

+0 over 3 months
  • Apr 9
  • May 9
  • Jul 9

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 44 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 83%
  • Will renew 5
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 75% 4 answers
  • Director 100% 2 answers
  • 8.4/10 Average score from customers who will renew
  • 9/10 Average score from undecided customers

For people who use Lonza Biologics

Do you use Lonza Biologics at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Lonza Biologics have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.